Mifepristone-misoprostol vs. Misoprostol Alone for Second Trimester Fetal Death
Mifepristone and Misoprostol Versus Misoprostol Alone for Treatment of Fetal Death at 14-28 Weeks of Pregnancy: A Randomized, Placebo-controlled Double-blinded Trial
Sponsor: Gynuity Health Projects
Terminated
Lack of funding
A PHASE3 clinical study on Fetal Death, this trial is terminated or withdrawn. The trial is conducted by Gynuity Health Projects and has accumulated 8 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Mar 2019 — Jan 2021 [monthly]
Terminated PHASE3
Status: Active Not Recruiting → Terminated
-
Dec 2018 — Mar 2019 [monthly]
Active Not Recruiting PHASE3
Status: Unknown Status → Active Not Recruiting
▶ Show 3 earlier versions
-
Aug 2018 — Dec 2018 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE3
First recorded
Apr 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Gynuity Health Projects
For direct contact, visit the study record on ClinicalTrials.gov .